Hedge Fund Winners in FDA Panel’s Regeneron Decision $REGN

A new eye medicine from Regeneron Pharmaceuticals (REGN) and Bayer AG was a safe and effective way of treating vision loss from macular degeneration, a U.S.

Keep Reading →